Novel blood test predicts sudden death risk patients who would benefit from ICDs

Posted by & filed under Health Sciences.

A novel blood test that predicts sudden death risk in heart failure patients is set to help physicians decide which patients would benefit from implantable cardioverter defibrillators (ICDs). Approximately 5 million patients in the US have heart failure, a condition where the heart is unable to pump blood adequately, and nearly 550,000 people are diagnosed annually. Heart failure is the single most common cause of admission to hospitals in the US.

Comments are closed.

Feedback

eSTEM Feedback

We appreciate any and all feedback about our site; praise, ideas, bug reports you name it!

e.g. Indifferent, Undecided, Unconcerned e.g.Kidding, Amused, Silly e.g. Happy, Confident, Grateful e.g. Sad, Dissapointed, Confused, Angry